GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Median PS Value

LTR Pharma (ASX:LTP) Median PS Value : A$0.00 (As of Jun. 07, 2024)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. LTR Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was A$. LTR Pharma's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is A$0.00.

As of today (2024-06-07), LTR Pharma's share price is A$0.64. LTR Pharma's Median PS Value is A$0.00. Therefore, LTR Pharma's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for LTR Pharma's Median PS Value or its related term are showing as below:

ASX:LTP's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.68
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

LTR Pharma Median PS Value Historical Data

The historical data trend for LTR Pharma's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Median PS Value Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Median PS Value
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Median PS Value - - -

Competitive Comparison of LTR Pharma's Median PS Value

For the Biotechnology subindustry, LTR Pharma's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LTR Pharma's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Price-to-Median-PS-Value falls into.



LTR Pharma Median PS Value Calculation

LTR Pharma's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=*
=

10-Year Median PS Ratio is .
For company reported annually, GuruFocus uses latest annual data as the TTM data. LTR Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was A$.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LTR Pharma  (ASX:LTP) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

LTR Pharma's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.64/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LTR Pharma Median PS Value Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


LTR Pharma (ASX:LTP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines